Why This Conversation Matters

Many patients are using cannabis and not telling their providers. A 2023 survey found that over 50% of medical cannabis users had not informed their primary care physician. Non-judgmental inquiry opens the door to safer use, better monitoring, and earlier identification of problems.

Most clinicians receive minimal cannabis education in training. Patients notice. When a provider can speak knowledgeably and without judgment, patients are far more likely to disclose use and engage in honest conversation about risks and benefits.

Opening the Conversation

Normalize the topic. Frame it as routine clinical inquiry, not interrogation.

• "Many of my patients have questions about cannabis. Is that something you've thought about or tried?"
• "I want to make sure we're accounting for everything you're taking, including supplements and cannabis products."
• "Cannabis can interact with some medications, so it's helpful for me to know if you use it — no judgment either way."
• "Some patients have found cannabis helpful for [their condition]. Have you considered it or tried it?"

Key Principles

• Lead with curiosity, not judgment. Your role is to inform and monitor, not to approve or disapprove.
• Acknowledge the evidence is mixed. Don't oversell cannabis as medicine, but don't dismiss patient experiences either.
• Focus on harm reduction when patients are already using. Meeting them where they are is more effective than abstinence-only messaging.
• Distinguish between recreational and medicinal goals. The conversation and clinical concerns differ.
• Be specific about the condition. Evidence varies dramatically by condition — chronic pain evidence differs from anxiety evidence.
• Ask about method, dose, and frequency. A patient vaping concentrates daily has a very different risk profile from someone using a CBD tincture occasionally.

Common Patient Questions & Evidence-Based Responses

"Will cannabis help my anxiety?"

The honest answer is: it depends. Low-dose THC and CBD may reduce anxiety, but higher THC doses frequently worsen it. This dose-response paradox is well-documented. If a patient wants to try cannabis for anxiety, recommend CBD-dominant or balanced (1:1) products, low doses, and careful tracking. Monitor for worsening symptoms.

"Is cannabis addictive?"

Yes, for some people. About 10% of all users and approximately 30% of regular users develop cannabis use disorder. The risk increases with earlier age of onset, higher potency products, daily use, and personal or family history of substance use disorders. Being honest about this builds trust.

"Is smoking cannabis bad for my lungs?"

Combustion produces carcinogens and respiratory irritants regardless of what's being burned. Regular cannabis smoking is associated with bronchitis symptoms. Recommend non-combustion routes: dry herb vaporizers, edibles, tinctures, or topicals reduce respiratory risk significantly.

"Can I use cannabis with my medications?"

Cannabis (especially CBD) affects CYP450 enzymes and can alter levels of many common medications. This isn't a yes/no question — it requires reviewing the specific medications. See our Safety Reference for a drug interaction table.

"What about CBD products?"

CBD is generally well-tolerated and non-intoxicating. However: it can interact with medications (CYP450 inhibition), product quality varies dramatically (FDA does not regulate most CBD products), and many products contain more or less CBD than labeled. Recommend products from licensed dispensaries with certificates of analysis.

"Is cannabis safe during pregnancy?"

No. The evidence consistently shows risk. THC crosses the placenta and is present in breast milk. Studies associate prenatal cannabis exposure with lower birth weight, preterm birth, and potential neurodevelopmental effects. Recommend cessation. Offer support resources.

When to Express Concern

If you notice signs of problematic use, raise it using MI-informed language:

• "I've noticed you're using more frequently than when we first discussed this. How are you feeling about your use?"
• "You mentioned you've been having trouble sleeping without it. That can sometimes be a sign of dependence developing. What do you think?"
• "I want to check in — is cannabis still serving you the way you intended, or has the relationship shifted?"

For patients who may be developing CUD, our companion site CannabisDependence.org offers comprehensive resources including screening tools and clinical materials for CUD treatment.

Provider-patient communication about cannabis use remains a significant gap in clinical practice. Studies show that normalizing the conversation and using non-judgmental language significantly increases patient disclosure and engagement in harm reduction strategies.

Haug et al., Journal of General Internal Medicine, 2023